Zona Glomerulosa Adenoma – Comprehensive Medical Guide

Overview

A zona glomerulosa adenoma (ZGA) is a rare, benign tumor that arises from the cells of the zona glomerulosa – the outermost layer of the adrenal cortex. These cells normally produce the mineralocorticoid hormone aldosterone. When an adenoma develops, it can secrete excess aldosterone, leading to a condition known as primary hyperaldosteronism (Conn’s syndrome).

Who it affects: ZGAs occur most often in adults aged 30–60 years, with a slight female predominance (about 55 % of cases). The condition is uncommon, accounting for roughly 5–10 % of all adrenal cortical adenomas, which themselves are found in ~3 % of the general population on imaging performed for unrelated reasons.¹

Because the tumor is usually small (often <2 cm) and asymptomatic in its early stages, many cases are discovered incidentally during abdominal CT or MRI performed for other reasons – a scenario commonly referred to as an “incidentaloma.”²

Symptoms

The clinical picture of a zona glomerulosa adenoma is driven by excess aldosterone, which promotes sodium retention, potassium loss, and volume expansion. Symptoms can range from subtle to severe.

• Hypertension – Persistent high blood pressure is the most common manifestation, occurring in >80 % of patients. It may be resistant to standard antihypertensive therapy.
• Hypokalemia – Low serum potassium (usually <3.5 mmol/L) can cause:
  • Muscle weakness or cramping
  • Fatigue
  • Paraesthesias (tingling)
  • Arrhythmias (palpitations, irregular heartbeat)
• Metabolic alkalosis – Due to increased hydrogen ion excretion, patients may have elevated blood pH, leading to light‑headedness or confusion.
• Headache – Often related to uncontrolled hypertension.
• Nocturia – Increased urine output at night because of pressure‑natriuresis.
• Polydipsia – Excess thirst secondary to fluid shifts.
• Cardiovascular complications – Over time, uncontrolled hypertension can cause left‑ventricular hypertrophy, heart failure, or stroke.
• Renal effects – Chronic sodium overload may lead to proteinuria or reduced kidney function.

Some patients remain asymptomatic; their condition is identified only by routine lab work showing low potassium or an incidental adrenal mass.

Causes and Risk Factors

The exact cause of ZGA is not fully understood, but several mechanisms have been suggested:

• Somatic mutations – Mutations in genes that regulate aldosterone synthesis, especially KCNJ5, CACNA1D, ATP1A1, and CLCN2, have been identified in up to 60 % of aldosterone‑producing adenomas.³
• Age – Incidence rises after the third decade, reflecting accumulated somatic mutations.
• Female sex – Hormonal factors may contribute to the slight female predominance.
• Family history of primary hyperaldosteronism – Rare hereditary forms (e.g., familial hyperaldosteronism type I) increase susceptibility.
• Obesity and metabolic syndrome – These conditions are linked to higher rates of adrenal incidentalomas, though a direct causal link to ZGA is still under investigation.

Diagnosis

Diagnosing a zona glomerulosa adenoma involves a stepwise approach that confirms excess aldosterone, excludes other causes, and identifies the tumor.

1. Biochemical Screening

• Plasma aldosterone concentration (PAC) and plasma renin activity (PRA) – The aldosterone‑to‑renin ratio (ARR) is the primary screen. An ARR >20 (with PAC >15 ng/dL) strongly suggests primary hyperaldosteronism.⁴
• 24‑hour urinary aldosterone – Helps confirm autonomous secretion, especially when medications interfere with the ARR.
• Serum electrolytes – Look for hypokalemia and metabolic alkalosis.

2. Confirmatory Tests

Because some drugs and dietary sodium intake can alter the ARR, confirmatory testing is recommended:

• Saline infusion test – 2 L of isotonic saline is infused over 4 hours; PAC should suppress (<15 ng/dL). Failure to suppress confirms autonomous secretion.
• Captopril challenge – An ACE‑inhibitor is given; in primary hyperaldosteronism, PAC remains elevated.
• Fludrocortisone suppression test – Less commonly used; monitors aldosterone response over several days.

3. Imaging

• CT abdomen (preferred) or MRI – Detects adrenal masses >1 cm. Typical adenoma features:
  • Well‑circumscribed
  • Homogeneous attenuation (<10 Hounsfield units) on non‑contrast CT
  • Rapid contrast wash‑out (>50 % at 10 minutes)
• Adrenal vein sampling (AVS) – The gold standard to determine lateralization (right vs left gland) when imaging is equivocal or bilateral lesions are present. A >4:1 aldosterone ratio between adrenal veins confirms a unilateral source, supporting surgical removal.

4. Histopathology (post‑surgery)

If the lesion is removed, pathology confirms a benign adenoma composed of zona glomerulosa‑type cells with lipid‑poor cytoplasm and positive immunostaining for aldosterone synthase (CYP11B2).⁵

Treatment Options

Therapeutic goals are to control blood pressure, correct electrolyte disturbances, and cure or minimize excess aldosterone production.

1. Surgical Management

• Laparoscopic adrenalectomy (preferred) – Minimally invasive removal of the affected gland. Success rates >90 % for cure of hypertension and normalization of potassium.⁶
• Open adrenalectomy – Reserved for very large tumors (>6 cm) or suspicion of malignancy.
• Partial (cortical‑sparing) adrenalectomy – Considered in patients with bilateral disease to preserve adrenal cortical reserve.

2. Medical Therapy

If surgery is contraindicated (e.g., severe comorbidities) or the patient declines operation, medical treatment focuses on antagonizing aldosterone’s effects.

• Mineralocorticoid receptor antagonists (MRAs):
  • Spironolactone – Starting dose 25‑50 mg daily, titrated to 100‑200 mg.
  • Eplerenone – More selective, fewer anti‑androgen side effects; 25‑50 mg twice daily.
  Both improve blood pressure and correct hypokalemia in >70 % of patients.⁷
• Potassium supplements – Oral potassium chloride if serum K⁺ remains <3.5 mmol/L despite MRAs.

3. Lifestyle & Adjunctive Measures

• Low‑sodium diet – < 2 g of sodium per day (≈5 g salt) reduces volume overload.
• Potassium‑rich foods – Bananas, oranges, potatoes, beans, and leafy greens.
• Regular aerobic exercise – Helps lower blood pressure and improves cardiovascular health.

Living with Zona Glomerulosa Adenoma

Even after definitive treatment, many patients benefit from ongoing self‑care.

• Blood pressure monitoring – Check daily at home; keep a log for your clinician.
• Electrolyte checks – At least twice yearly, or more often if you remain on MRAs.
• Medication adherence – Take MRAs exactly as prescribed; missed doses can precipitate rebound hypertension.
• Follow‑up imaging – A repeat CT or MRI is usually performed 6‑12 months post‑surgery to confirm no residual mass.
• Stress management – Chronic hypertension can be worsened by stress; techniques like meditation, yoga, or counseling are beneficial.
• Vaccinations – Keep up to date with influenza and COVID‑19 vaccines; infections can trigger blood‑pressure spikes.

Prevention

Because ZGA originates from spontaneous somatic mutations, primary prevention is limited. However, the following strategies can reduce overall risk of adrenal incidentalomas and mitigate the impact of excess aldosterone:

• Maintain a healthy weight (BMI < 25 kg/m²) – obesity is linked to higher rates of adrenal nodules.
• Adopt a low‑sodium diet – Chronic high‑salt intake may exacerbate aldosterone‑driven hypertension.
• Control blood pressure early – Treating mild hypertension may limit the clinical sequelae if a ZGA later develops.
• Avoid excessive alcohol and tobacco – Both contribute to cardiovascular strain.
• Regular health check‑ups – Routine labs (electrolytes, renal function) can detect early hypokalemia.

Complications

If left untreated, prolonged exposure to high aldosterone levels can cause serious complications:

• Resistant hypertension – May require multiple antihypertensive agents and increases cardiovascular mortality.
• Cardiovascular disease – Left‑ventricular hypertrophy, coronary artery disease, heart failure, and stroke.
• Chronic kidney disease – Sodium‑induced glomerular hyperfiltration can lead to progressive renal insufficiency.
• Severe hypokalemia – Can precipitate life‑threatening arrhythmias, muscle paralysis, and rhabdomyolysis.
• Metabolic alkalosis – May cause respiratory compensation difficulties in patients with chronic lung disease.

When to Seek Emergency Care

References:

1. Mayo Clinic. “Adrenal incidentaloma.” Updated 2023.
2. National Institutes of Health (NIH). “Adrenal tumors: Diagnosis and management.” 2022.
3. Gomez‑Saez, E. et al. “Somatic mutations in aldosterone‑producing adenomas.” J Clin Endocrinol Metab. 2021.
4. American College of Cardiology/American Heart Association. “Guideline for the Diagnosis and Treatment of Primary Aldosteronism.” 2022.
5. Cleveland Clinic. “Pathology of adrenal cortical adenomas.” 2023.
6. Schwartz, L. et al. “Outcomes after laparoscopic adrenalectomy for aldosterone‑producing adenomas.” Ann Surg. 2020.
7. European Society of Hypertension. “Mineralocorticoid receptor antagonists in primary hyperaldosteronism.” 2021.